Back to Diseases

Polycystic Ovary Syndrome (PCOS)

An authoritative clinical profile of Polycystic Ovary Syndrome (PCOS) covering 2023 Rotterdam criteria, hyperandrogenism vs insulin resistance dynamics, ovarian torsion emergency red flags, and metabolic screening non-replacement rules.

Consensus-GuidanceReviewed: Jul 31, 2026

Editorial review complete

Independent clinical validation is pending.

Validation pending

Quick Reference Facts

System AffinityDermatology
Diagnostic StandardClinical evaluation & serum biomarkers
Urgency Levelroutine
Evidence GradeConsensus-Guidance

Visual guide

Transparent clinical anatomy model showing the uterus, ovaries, and fallopian tubes
Homeo Healthcare
Understanding the ovaries
Indian woman privately filling in a personal planner in a colourful community library
Homeo Healthcare
A patient-owned planning moment
Abstract ruby and aqua glass contours surrounding a luminous cluster of pearl-like spheres
Homeo Healthcare
A closer look at signalling

In simple words

Polycystic Ovary Syndrome (PCOS) is a complex endocrine-metabolic disorder defined by the 2023 International Rotterdam criteria requiring at least 2 of 3 features: ovulatory dysfunction (oligo-/amenorrhea), hyperandrogenism (clinical or biochemical), and polycystic ovarian morphology on ultrasound [D0013-KEYNOTES, CIT-0045].

What it means

A heterogenous reproductive and metabolic endocrinopathy characterized by anovulation, hyperandrogenemia, insulin resistance, and characteristic ovarian follicular microcysts.

Common causes

  • Insulin resistance and compensatory hyperinsulinemia stimulating ovarian androgen synthesis [D0013-KEYNOTES, CIT-0045]
  • Altered hypothalamic-pituitary LH/FSH pulse frequency favoring excess luteinizing hormone secretion
  • Genetic polygenic architecture interacting with sedentary lifestyle and weight gain

Risk Factors

  • First-degree family history of PCOS or Type 2 Diabetes Mellitus
  • Obesity, central adiposity, and metabolic syndrome
  • Premature adrenarche or early-onset childhood weight gain

Common symptoms

  • Irregular, infrequent, or absent menstrual cycles (oligo- or amenorrhea) [D0013-KEYNOTES, CIT-0045]
  • Hirsutism (excessive terminal facial/body hair), severe recalcitrant acne, and androgenic alopecia
  • Acanthosis nigricans (velvety hyperpigmentation of neck/axillae), weight gain, and infertility

Lifestyle & diet support

Engage in 150+ minutes of weekly aerobic and resistance exercise, consume a low-glycemic Mediterranean-style diet, manage stress, and track menstrual cycle regularity.

Treatment Approaches

Conventional Management

Management includes lifestyle weight management, combined oral contraceptive pills (COCPs) for cycle regulation, metformin for insulin resistance, anti-androgens (spironolactone) for hirsutism, and letrozole/clomiphene for ovulation induction [CIT-0045].

Homeopathic Approach

Homeopathic remedies (such as Pulsatilla, Sepia, Calcarea Carbonica, Thuja) provide supportive constitutional care to assist in menstrual regularity, soothe associated acne, and enhance general vitality alongside metabolic monitoring.

Frequently Asked Questions

Sudden, acute, severe unilateral pelvic pain accompanied by nausea, vomiting, fever, or peritoneal signs indicates POSSIBLE OVARIAN TORSION OR RUPTURED HEMORRHAGIC CYST [D0013-EMERGENCY-LIMITS, CIT-0045]. This is a SURGICAL EMERGENCY requiring IMMEDIATE ER evaluation.
NO. Homeopathy MUST NOT be used to replace diagnostic pelvic ultrasound, glucose tolerance testing, or endometrial protection in prolonged amenorrhea [D0013-REGULATORY-LIMITS]. Unopposed estrogen in prolonged amenorrhea increases endometrial cancer risk.
Homeopathy serves as complementary constitutional care alongside routine metabolic screening, pelvic ultrasound, and gynecological supervision [D0013-REGULATORY-LIMITS].
Clinical & academic detailShow detail

Diagnosis & tests

Investigation Protocol

Evaluated via serum free/total testosterone, DHEAS, LH/FSH ratio, fasting glucose/insulin (OGTT), lipid panel, serum progesterone, and pelvic transvaginal/abdominal ultrasound showing ≥20 follicles per ovary or volume ≥10 mL [CIT-0045].

Differential Diagnosis

Differentiate PCOS from Thyroid Dysfunction, Hyperprolactinemia, Non-Classic Congenital Adrenal Hyperplasia (NCCAH), Cushing Syndrome, and Androgen-Secreting Ovarian Tumors.

Differential Diagnosis Matrix

Differential Diagnosis Overview

Differentiate PCOS from Thyroid Dysfunction, Hyperprolactinemia, Non-Classic Congenital Adrenal Hyperplasia (NCCAH), Cushing Syndrome, and Androgen-Secreting Ovarian Tumors.

Reference Citations & Evidence Sources

Clinical Guidelines & Consensus Statements
  • CIT-0045Teede H. J., Tay C. T., Laven J. J.. "Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS)." Fertility and Sterility (2023).DOI PubMed
Materia Medica & Keynotes
  • CIT-0004Hahnemann S.. "Materia Medica Pura." Adolph Arnold (1811).
  • CIT-0005Kent J. T.. "Lectures on Homoeopathic Materia Medica." Boericke & Tafel (1905).
  • CIT-0006Boericke W.. "Pocket Manual of Homoeopathic Materia Medica." Boericke & Runyon (1901).

No clinical connections registered for this topic.

Patient Clinical Support

Seeking Expert Consultation?

Book an online video session with Dr. Narayan Jethwani to get an individualized constitutional homeopathic protocol tailored to your case.

Book Consultation

Medical Safety Disclaimer

All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.